Trials / Conditions / Adult-Onset Still's Disease
Adult-Onset Still's Disease
6 registered clinical trials studyying Adult-Onset Still's Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease NCT07151157 | Ruijin Hospital | N/A |
| Withdrawn | Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD) NCT05432960 | R-Pharm International, LLC | Phase 3 |
| Completed | Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD NCT04717635 | Novartis Pharmaceuticals | Phase 3 |
| Terminated | A Study to Evaluate Camoteskimab in Participants With Still's Disease NCT04752371 | Apollo Therapeutics Ltd | Phase 1 |
| Terminated | Canakinumab for Treatment of Adult-onset Still's Disease NCT02204293 | Charite University, Berlin, Germany | Phase 2 |
| Completed | Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study NCT01033656 | University of Helsinki | Phase 2 |